Literature DB >> 25983287

Incentives for smoking cessation.

Kate Cahill1, Jamie Hartmann-Boyce, Rafael Perera.   

Abstract

BACKGROUND: Material or financial incentives are widely used in an attempt to precipitate or reinforce behaviour change, including smoking cessation. They operate in workplaces, in clinics and hospitals, and to a lesser extent within community programmes. In this third update of our review we now include trials conducted in pregnant women, to reflect the increasing activity and resources now targeting this high-risk group of smokers.
OBJECTIVES: To determine whether incentives and contingency management programmes lead to higher long-term quit rates. SEARCH
METHODS: We searched the Cochrane Tobacco Addiction Group Specialised Register, with additional searches of MEDLINE, EMBASE, CINAHL and PsycINFO. The most recent searches were in December 2014, although we also include two trials published in 2015. SELECTION CRITERIA: We considered randomised controlled trials, allocating individuals, workplaces, groups within workplaces, or communities to experimental or control conditions. We also considered controlled studies with baseline and post-intervention measures. We include studies in a mixed-population setting (e.g. community-, work-, institution-based), and also, for this update, trials in pregnant smokers. DATA COLLECTION AND ANALYSIS: One author (KC) extracted data and a second (JH-B) checked them. We contacted study authors for additional data where necessary. The main outcome measure in the mixed-population studies was abstinence from smoking at longest follow-up, and at least six months from the start of the intervention. In the trials of pregnant smokers abstinence was measured at the longest follow-up, and at least to the end of the pregnancy. MAIN
RESULTS: Twenty-one mixed-population studies met our inclusion criteria, covering more than 8400 participants. Ten studies were set in clinics or health centres, one in Thai villages served by community health workers, two in academic institutions, and the rest in worksites. All but six of the trials were run in the USA. The incentives included lottery tickets or prize draws, cash payments, vouchers for goods and groceries, and in six trials the recovery of money deposited by those taking part. The odds ratio (OR) for quitting with incentives at longest follow-up (six months or more) compared with controls was 1.42 (95% confidence interval (CI) 1.19 to 1.69; 17 trials, [20 comparisons], 7715 participants). Only three studies demonstrated significantly higher quit rates for the incentives group than for the control group at or beyond the six-month assessment: One five-arm USA trial compared rewards- and deposit-based interventions at individual and group level, with incentives available up to USD 800 per quitter, and demonstrated a quit rate in the rewards groups of 8.1% at 12 months, compared with 4.7% in the deposits groups. A direct comparison between the rewards-based and the deposit-based groups found a benefit for the rewards arms, with an OR at 12 months of 1.76 (95% CI 1.22 to 2.53; 2070 participants). Although more people in this trial accepted the rewards programmes than the deposit programmes, the proportion of quitters in each group favoured the deposit-refund programme. Another USA study rewarded both participation and quitting up to USD 750, and achieved sustained quit rates of 9.4% in the incentives group compared with 3.6% for the controls. A deposit-refund trial in Thailand also achieved significantly higher quit rates in the intervention group (44.2%) compared with the control group (18.8%), but uptake was relatively low, at 10.5%. In the remaining trials, there was no clear evidence that participants who committed their own money to the programme did better than those who did not, or that contingent rewards enhanced success rates over fixed payment schedules. We rated the overall quality of the older studies as low, but with later trials (post-2000) more likely to meet current standards of methodology and reporting.Eight of nine trials with usable data in pregnant smokers (seven conducted in the USA and one in the UK) delivered an adjusted OR at longest follow-up (up to 24 weeks post-partum) of 3.60 (95% CI 2.39 to 5.43; 1295 participants, moderate-quality studies) in favour of incentives. Three of the trials demonstrated a clear benefit for contingent rewards; one delivered monthly vouchers to confirmed quitters and to their designated 'significant other supporter', achieving a quit rate in the intervention group of 21.4% at two months post-partum, compared with 5.9% among the controls. Another trial offered a scaled programme of rewards for the percentage of smoking reduction achieved over the course of the 12-week intervention, and achieved an intervention quit rate of 31% at six weeks post-partum, compared with no quitters in the control group. The largest (UK-based) trial provided intervention quitters with up to GBP 400-worth of vouchers, and achieved a quit rate of 15.4% at longest follow-up, compared to the control quit rate of 4%. Four trials confirmed that payments made to reward a successful quit attempt (i.e. contingent), compared to fixed payments for attending the antenatal appointment (non-contingent), resulted in higher quit rates. Front-loading of rewards to counteract early withdrawal symptoms made little difference to quit rates. AUTHORS'
CONCLUSIONS: Incentives appear to boost cessation rates while they are in place. The two trials recruiting from work sites that achieved sustained success rates beyond the reward schedule concentrated their resources into substantial cash payments for abstinence. Such an approach may only be feasible where independently-funded smoking cessation programmes are already available, and within a relatively affluent and educated population. Deposit-refund trials can suffer from relatively low rates of uptake, but those who do sign up and contribute their own money may achieve higher quit rates than reward-only participants. Incentive schemes conducted among pregnant smokers improved the cessation rates, both at the end-of-pregnancy and post-partum assessments. Current and future research might continue to explore the scale, loading and longevity of possible cash or voucher reward schedules, within a variety of smoking populations.

Entities:  

Mesh:

Year:  2015        PMID: 25983287     DOI: 10.1002/14651858.CD004307.pub5

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  61 in total

Review 1.  Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?

Authors:  Nancy M Petry; Sheila M Alessi; Todd A Olmstead; Carla J Rash; Kristyn Zajac
Journal:  Psychol Addict Behav       Date:  2017-06-22

2.  A qualitative study to assess perceptions, barriers, and motivators supporting smokeless tobacco cessation in the US fire service.

Authors:  Nattinee Jitnarin; Walker S C Poston; Sara A Jahnke; Christopher K Haddock; Hannah N Kelley; Herbert H Severson
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

3.  Application of a Brief Incentive Treatment for Cigarette Smoking.

Authors:  Ryan Redner; Nicolette Robertson; Stephanie Lo
Journal:  Behav Anal Pract       Date:  2018-03-09

4.  Medicaid Incentives for Preventing Chronic Disease: Effects of Financial Incentives for Smoking Cessation.

Authors:  Allison Witman; Joseph Acquah; Maria Alva; Thomas Hoerger; Melissa Romaire
Journal:  Health Serv Res       Date:  2018-06-12       Impact factor: 3.402

5.  Financial Incentives Promote Smoking Cessation Directly, Not by Increasing Use of Cessation Aids.

Authors:  Michael O Harhay; Andrea B Troxel; Christine Brophy; Kathryn Saulsgiver; Kevin G Volpp; Scott D Halpern
Journal:  Ann Am Thorac Soc       Date:  2019-02

Review 6.  Reducing tobacco use among women of childbearing age: Contributions of tobacco regulatory science and tobacco control.

Authors:  Allison N Kurti
Journal:  Exp Clin Psychopharmacol       Date:  2019-12-19       Impact factor: 3.157

7.  Contingency Management Versus Psychotherapy for Prenatal Smoking Cessation: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Sarah M Wilson; Amie R Newins; Alyssa M Medenblik; Nathan A Kimbrel; Eric A Dedert; Terrell A Hicks; Lydia C Neal; Jean C Beckham; Patrick S Calhoun
Journal:  Womens Health Issues       Date:  2018-07-27

8.  Capsule Commentary on Huskamp et al., Effects of Global Payment and Accountable Care on Tobacco Cessation Service Use: An Observational Study.

Authors:  Jeffrey L Jackson
Journal:  J Gen Intern Med       Date:  2016-10       Impact factor: 5.128

9.  Contingency management for college student smokers: The role of drinking as a moderator and mediator of smoking abstinence during treatment.

Authors:  Rachel N Cassidy; Kristina M Jackson; Damaris J Rohsenow; Jennifer W Tidey; Tracy O' L Tevyaw; Nancy P Barnett; Peter M Monti; Mollie E Miller; Suzanne M Colby
Journal:  Addict Behav       Date:  2018-01-31       Impact factor: 3.913

10.  Simulating demand for cigarettes among pregnant women: A Low-Risk method for studying vulnerable populations.

Authors:  Stephen T Higgins; Derek D Reed; Ryan Redner; Joan M Skelly; Ivori A Zvorsky; Allison N Kurti
Journal:  J Exp Anal Behav       Date:  2016-12-21       Impact factor: 2.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.